CYPH - Cytoclonal Pharmaceutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics

CYPH 1.530

-9.5%

Nov 28 12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: lazarre who wrote (175)	6/17/1998 12:32:00 PM
From: Sir Auric Goldfinger	Read Replies (1) of 428

CYPH is a questionable company with the cash level cited as well as the burn rate that will chew up all of it's cash within the next quarter. It has no revenues and sells at a price to cash of 92X and a price to book of 190X. These are extremely high ratios for any Company and there is much insider selling. I am saying that Janssen Meyers deals are very questionable and their relationship to Dryefus vis a vis CCSI and MCHM are well chronicled on SI as well as thestreet.com and Business Week. This is an excellent short! All of the above in my opinion. All rights reserved, Auric Goldfinger.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next